Pfizer Inc said on Friday the U.S. Food and Drug Administration has approved its lung-cancer treatment for patients with a specific gene mutation who had been previously treated for an aggressive form of the disease.
from Reuters: Health News https://ift.tt/2EZ7ocF
0 comments:
Post a Comment